Viewing Study NCT00542269


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-02-06 @ 9:36 AM
Study NCT ID: NCT00542269
Status: TERMINATED
Last Update Posted: 2011-05-24
First Post: 2007-10-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CSPP100AGB01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: External Affairs
Old Organization: Novartis

Collaborators